ClinicalTrials.gov record
Completed Phase 2 Interventional

A Study of RO4905417 in Patients With Non ST-Elevation Myocardial Infarction (Non-STEMI) Undergoing Percutaneous Coronary Intervention

ClinicalTrials.gov ID: NCT01327183

Public ClinicalTrials.gov record NCT01327183. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 11, 2026, 2:54 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF 2 DOSES OF RO4905417 (R1512) ADMINISTERED TO PATIENTS WITH NON ST-ELEVATION MYOCARDIAL INFARCTION (NON-STEMI) UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (PCI)

Study identification

NCT ID
NCT01327183
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Hoffmann-La Roche
Industry
Enrollment
532 participants

Conditions and interventions

Interventions

  • Percutaneous Coronary Intervention (PCI) Procedure
  • RO4905417 Drug
  • placebo Drug

Procedure · Drug

Eligibility (public fields only)

Age range
19 Years to 74 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2011
Primary completion
Sep 30, 2012
Completion
Sep 30, 2012
Last update posted
Nov 1, 2016

2011 – 2012

United States locations

U.S. sites
35
U.S. states
24
U.S. cities
34
Facility City State ZIP Site status
Not listed Huntsville Alabama 35801
Not listed Tucson Arizona 85710
Not listed Los Angeles California 90022
Not listed Salinas California 93901
Not listed Littleton Colorado 80120
Not listed Farmington Connecticut 06030
Not listed Boynton Beach Florida 33472
Not listed Kissimmee Florida 34741
Not listed Ocala Florida 34471
Not listed Sarasota Florida 34239
Not listed St. Petersburg Florida 33701
Not listed Tampa Florida 33613
Not listed Vero Beach Florida 32960
Not listed Columbus Georgia 31904
Not listed Aurora Illinois 60504
Not listed Fort Wayne Indiana 46804
Not listed Iowa City Iowa 52242
Not listed Wichita Kansas 67214
Not listed Louisville Kentucky 40205
Not listed Shreveport Louisiana 71103
Not listed Baltimore Massachusetts 21287
Not listed Hyannis Massachusetts 02601
Not listed Bay City Michigan 48708
Not listed Petoskey Michigan 49770
Not listed Saint Paul Minnesota 55102
Not listed Ridgewood New Jersey 07450
Not listed Johnson City New York 13790
Not listed Raleigh North Carolina 27610
Not listed Bismarck North Dakota 58501
Not listed Springfield Ohio 45505
Not listed Toledo Ohio 43606
Not listed Oklahoma City Oklahoma 73109
Not listed Oklahoma City Oklahoma 73120
Not listed Chambersburg Pennsylvania 17201
Not listed Houston Texas 77024

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 31 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01327183, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 1, 2016 · Synced May 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01327183 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →